Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a special purpose acquisition company operating within the biopharmaceutical sector. The company filed an 8-K with the Securities and Exchange Commission on September 8, 2026, under accession number 0001493152-26-041725, signaling a material corporate development reportable under exchange rules. PWUP is focused on identifying and completing a business combination with a target in the life sciences and biopharma space. For the full filing history, sponsor details, deal timeline, and current transaction status on PWUP, visit SpacDesk and sign up for complete SPAC data and real-time deal tracking.